How it works
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist. Unlike earlier medications that targeted a single hormone pathway, it mimics two natural incretin hormones to create a synergistic effect.
Tirzepatide mimics GLP-1, the incretin hormone that governs how full you feel and how your body handles glucose after a meal.
Tirzepatide is a first-in-class dual agonist: it also activates GIP, a second incretin pathway that earlier medications left untouched.
Working both incretin pathways at once corrects the hormonal signals that drive hunger and fat storage — which is why patients not only lose weight, but keep it off.
The reason tirzepatide has seen unprecedented success isn't just because people are losing weight — it's because they are keeping it off. For years, weight loss was treated as a test of willpower. We now know it's a matter of hormones. By correcting the hormonal signals that drive hunger and fat storage, tirzepatide levels the playing field.
The gold standard
8 years of GLP-1 innovation. 16 years of weight loss mastery. In a field now crowded with "pop-up" telehealth sites, our longevity is your safety net. We didn't just jump on a bandwagon; we helped build the road.
An in-depth look at your metabolic health to ensure tirzepatide is the right fit for you.
We carefully manage your dosage to maximize fat loss while minimizing side effects.
Regular check-ins to celebrate your wins and fine-tune your treatment for long-term maintenance.
Free · 2 Minutes · Physician-Built
BMI is just a number. Our free Health Report Card scores your real risk for five major conditions — then matches you to the medical weight loss path that can actually move those numbers.
Your report scores 5 risk areas
Patients drive to our Crowley clinic for tirzepatide from communities up to 35 miles away.
